Preventive capacity of subcutaneous immunotherapy

Area of Science:

• Allergy and Immunology
• Immunotherapy Research

Background:

• Allergic rhinitis is a common condition.
• Asthma can develop in individuals with allergic rhinitis.
• New allergic sensitizations can emerge over time.

Purpose of the Study:

• To review current literature on the preventive effects of allergen-specific subcutaneous injection immunotherapy.
• To highlight the capacity of immunotherapy to prevent allergic disease progression.

Main Methods:

• Literature review of important and interesting articles.
• Focus on preventive aspects and capacity of subcutaneous immunotherapy.

Main Results:

• Evidence suggests immunotherapy may prevent asthma development in allergic rhinitis patients.
• Immunotherapy shows potential in preventing new immunoglobulin E-mediated sensitizations.
• Subcutaneous immunotherapy is the only specific, curative treatment for immunoglobulin E-mediated allergy.

Conclusions:

• Subcutaneous immunotherapy demonstrates preventive capacity against new sensitizations and disease progression.
• Immunotherapy can induce prolonged clinical remission, suggesting earlier consideration in management.
• Large, multi-center studies are required to validate preventive aspects across different patient groups.